TY - JOUR
T1 - Nationwide one-year outcomes in acute myocardial infarction-related cardiogenic shock with a focus on broad-anterior myocardial infarction
T2 - Insights from a Japanese registry
AU - Arai, Riku
AU - Yamaji, Kyohei
AU - Kohsaka, Shun
AU - Mori, Yuichiro
AU - Ishii, Hideki
AU - Ando, Hirohiko
AU - Numasawa, Yohei
AU - Kojima, Keisuke
AU - Amano, Tetsuya
AU - Kozuma, Ken
AU - Okumura, Yasuo
N1 - Publisher Copyright:
© 2025 .
PY - 2025/12
Y1 - 2025/12
N2 - Background The one-year prognosis for patients with acute myocardial infarction complicated by cardiogenic shock (AMI-CS) undergoing percutaneous coronary intervention (PCI) has not been sufficiently characterized, particularly in nationwide registry analyses. Moreover, data comparing outcomes by infarct location, such as broad-anterior myocardial infarction (BA-MI) vs. non-BA-MI, remain scarce. Methods and Results We analyzed 2489 AMI-CS patients from the J-PCI OUTCOME registry, classifying them into BA-MI and non-BA-MI groups. BA-MI was defined as a culprit lesion in the left main trunk or proximal left anterior descending artery. One-year cumulative incidence in BA-MI vs. non-BA-MI was 16.2 % vs. 11.6 % ( p = 0.002) for all-cause death, 10.9 % vs. 7.2 % ( p = 0.002) for cardiac death, 5.9 % vs. 4.8 % ( p = 0.32) for non-cardiac death, and 6.3 % vs. 3.6 % ( p = 0.007) for heart failure hospitalization (HFH). BA-MI was independently associated with cardiac death (HR: 1.38; 95 % CI: 1.02–1.87; p = 0.04) and HFH (HR: 1.71; 95 % CI: 1.12–2.62; p = 0.01), but not with all-cause or non-cardiac death. Predictors of all-cause death included age > 80 years, diabetes, chronic kidney disease, cardiac arrest within 24 h, and veno-arterial extracorporeal membrane oxygenation (VA-ECMO) use, including VA-ECMO alone and VA-ECMO combined with either an intra-aortic balloon pump or an Impella device (Abiomed Inc., Danvers, MA, USA). Landmark analysis demonstrated that BA-MI was associated with an increased risk of HFH during the 31–365-day follow-up period. Among patients without VA-ECMO, BA-MI was significantly associated with all-cause death (HR: 1.36; 95 % CI: 1.04–1.79; p = 0.03). Conclusions In AMI-CS, BA-MI was independently linked to cardiac death and HFH, and to all-cause death in patients without VA-ECMO. HFH events in the BA-MI group accumulated progressively, and the difference compared with non-BA-MI became increasingly evident during the one-year follow-up. Traditional risk factors and VA-ECMO were associated with all-cause death.
AB - Background The one-year prognosis for patients with acute myocardial infarction complicated by cardiogenic shock (AMI-CS) undergoing percutaneous coronary intervention (PCI) has not been sufficiently characterized, particularly in nationwide registry analyses. Moreover, data comparing outcomes by infarct location, such as broad-anterior myocardial infarction (BA-MI) vs. non-BA-MI, remain scarce. Methods and Results We analyzed 2489 AMI-CS patients from the J-PCI OUTCOME registry, classifying them into BA-MI and non-BA-MI groups. BA-MI was defined as a culprit lesion in the left main trunk or proximal left anterior descending artery. One-year cumulative incidence in BA-MI vs. non-BA-MI was 16.2 % vs. 11.6 % ( p = 0.002) for all-cause death, 10.9 % vs. 7.2 % ( p = 0.002) for cardiac death, 5.9 % vs. 4.8 % ( p = 0.32) for non-cardiac death, and 6.3 % vs. 3.6 % ( p = 0.007) for heart failure hospitalization (HFH). BA-MI was independently associated with cardiac death (HR: 1.38; 95 % CI: 1.02–1.87; p = 0.04) and HFH (HR: 1.71; 95 % CI: 1.12–2.62; p = 0.01), but not with all-cause or non-cardiac death. Predictors of all-cause death included age > 80 years, diabetes, chronic kidney disease, cardiac arrest within 24 h, and veno-arterial extracorporeal membrane oxygenation (VA-ECMO) use, including VA-ECMO alone and VA-ECMO combined with either an intra-aortic balloon pump or an Impella device (Abiomed Inc., Danvers, MA, USA). Landmark analysis demonstrated that BA-MI was associated with an increased risk of HFH during the 31–365-day follow-up period. Among patients without VA-ECMO, BA-MI was significantly associated with all-cause death (HR: 1.36; 95 % CI: 1.04–1.79; p = 0.03). Conclusions In AMI-CS, BA-MI was independently linked to cardiac death and HFH, and to all-cause death in patients without VA-ECMO. HFH events in the BA-MI group accumulated progressively, and the difference compared with non-BA-MI became increasingly evident during the one-year follow-up. Traditional risk factors and VA-ECMO were associated with all-cause death.
KW - Acute myocardial infarction complicated with cardiogenic shock
KW - All-cause mortality
KW - Broad-anterior myocardial infarction
KW - Cardiac death
UR - https://www.scopus.com/pages/publications/105024116721
U2 - 10.1016/j.jjcc.2025.10.002
DO - 10.1016/j.jjcc.2025.10.002
M3 - Article
C2 - 41093035
AN - SCOPUS:105024116721
SN - 0914-5087
VL - 86
SP - 599
EP - 611
JO - Journal of Cardiology
JF - Journal of Cardiology
IS - 6
ER -